Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00402506 · ClinicalTrials.gov registry record · Phase 3

A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG

A Phase 3 study of Myocardial Ischemia and Reperfusion Injury, sponsored by Medicure.

Completed
Registry status
Phase 3
Development phase
3,000
Enrollment target
2
Study locations

NCT00402506 is a Phase 3 study of Myocardial Ischemia and Reperfusion Injury that has completed, run by Medicure. The registered enrollment target is 3,000 participants, above the 2,034-participant average among 29 other Myocardial Ischemia trials with a reported enrollment target (47% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00402506, a Phase 3 study of Myocardial Ischemia and Reperfusion Injury, has completed, sponsored by Medicure.

COMPLETED
Registry status
Phase 3
Development phase
3,000 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine the effect of MC-1 on the combined incidence of cardiovascular death and nonfatal myocardial infarction (MI) up to and including 30 days following coronary artery bypass graft (CABG) surgery compared with placebo.

Conditions Studied

Myocardial Ischemia Reperfusion Injury Coronary Artery Bypass Graft Surgery

Interventions

  • DRUG (MC-1) Pyridoxal 5'-phosphate

Study Locations (2)

North Carolina

  • Duke Clinical Research Institute - Durham

Quebec

  • Montreal Heart Institute - Montreal

Trial Details

FieldValue
Enrollment Target 3,000 participants
Start Date 2006-11
Est. Completion 2007-09
Phase Phase 3

Sponsor

Medicure

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00402506

The ClinicalTrials.gov registry entry for NCT00402506 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,034-participant average among 29 other Myocardial Ischemia trials with a reported enrollment target (47% higher). The listed sponsor is Medicure, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Myocardial Ischemia appearing as the primary indexed condition, and to 1 intervention - of which (MC-1) Pyridoxal 5'-phosphate is the first listed.

NCT00402506 reports 2 study locations spanning 2 distinct geographic areas - top geographies include North Carolina, Quebec.

Frequently Asked Questions

What is clinical trial NCT00402506 about?

NCT00402506 is a clinical study titled "A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG". The purpose of this study is to determine the effect of MC-1 on the combined incidence of cardiovascular death and nonfatal myocardial infarction (MI) up to and including 30 days following coronary artery bypass graft (CABG) surgery compared with placebo.

What is the current status of trial NCT00402506?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 3,000 participants. The study started on 2006-11. Estimated completion is 2007-09.

What conditions does trial NCT00402506 study?

This clinical trial studies the following conditions: Myocardial Ischemia, Reperfusion Injury, Coronary Artery Bypass Graft Surgery.

What interventions are being tested in trial NCT00402506?

The interventions under investigation include: (MC-1) Pyridoxal 5'-phosphate (DRUG).

Who is sponsoring clinical trial NCT00402506?

This trial is sponsored by Medicure, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00402506 being conducted?

This trial has 2 study locations across North Carolina, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myocardial Ischemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myocardial Ischemia

All registered trials for this condition

Reperfusion Injury

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.